BactiQuant AS (OCSE:BACTIQ) Stock Based Compensation: kr0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:BACTIQ BactiQuant AS OCSE:BACTIQ
56 GF Score
Price kr2.40
GF Value kr2.34
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS Stock Based Compensation?

BactiQuant AS OCSE:BACTIQ -2.04% 56 Stock Based Compensation is kr0.00 Mil as of Dec. 2025. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 56/100 and a GF Value™ of kr2.34 (Fairly Valued). The stock has 4 warning signs investors should review.

BactiQuant AS's Stock Based Compensation for the six months ended in Dec. 2025 was kr0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil.

BactiQuant AS Stock Based Compensation Related Terms

BactiQuant AS Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS Stock Based Compensation Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OCSE:BACTIQ
56GF Score
BactiQuant AS OCSE:BACTIQ
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BactiQuant AS Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

What does a Stock Based Compensation of kr0.00 Mil mean?
BactiQuant AS (OCSE:BACTIQ) has a Stock Based Compensation of kr0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for BactiQuant AS and its competitors.
Is BactiQuant AS's Stock Based Compensation too high?
BactiQuant AS's current Stock Based Compensation is kr0.00 Mil. Overall, BactiQuant AS has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Stock Based Compensation compare to VLTO and ZWS?
BactiQuant AS's Stock Based Compensation of kr0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for an Industrial Products company?
A good Stock Based Compensation depends on the Industrial Products industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for BactiQuant AS and its competitors. BactiQuant AS's current Stock Based Compensation is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.34, compared to a current price of kr2.40 — trading 2.6% above its estimated fair value. The current Stock Based Compensation is kr0.00 Mil. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Stock Based Compensation is kr0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of kr2.40 is trading 2.6% above its estimated GF Value™ of kr2.34. GuruFocus considers BactiQuant AS to be Fairly Valued.

Key valuation signals for OCSE:BACTIQ:

  • Stock Based Compensation: kr0.00 Mil
  • GF Value™: kr2.34 vs. price of kr2.40 (2.6% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BactiQuant AS Business Description

Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score

Get the complete analysis for OCSE:BACTIQ

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.40
Price
kr2.34
GF Value